Aion Therapeutic Inc. (CSE: AION) announces that further to its press releases of September 13, 2022, September 26, 2022, October 11, 2022 and October 31, 2022, it is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Cease Trade Orders for Continuous Disclosure Defaults (“NP 12-203“). On…

Aion Therapeutic Inc. (CSE: AION) announces that further to its press releases of September 13, 2022, September 26, 2022 and October 11, 2022, it is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Cease Trade Orders for Continuous Disclosure Defaults (“NP 12-203”). On August 30, 2022,…

We’re excited to announce that we’ve added 12 new companies to the Psychedelic Invest Index – making us fully up to date on all the recent listings. The Psychedelic Invest Index, the first ever to track the entire public sector of the psychedelic market, now features: Field Trip Health: FTRP:CSE Compass Pathways: CMPS:NASDAQ Mindcure: MCUR:CSE…